Obese or lean: Whom to prescribe sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction?

Eur J Heart Fail. 2024 Apr;26(4):910-911. doi: 10.1002/ejhf.3261. Epub 2024 Apr 28.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Heart Failure* / drug therapy
  • Heart Failure* / physiopathology
  • Humans
  • Obesity* / complications
  • Obesity* / drug therapy
  • Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
  • Stroke Volume* / physiology

Substances

  • Sodium-Glucose Transporter 2 Inhibitors